- Home
- RLMD vs JUNS Comparison
RLMD vs JUNS Comparison
Compare RLMD & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- JUNS
- Stock Information
- Founded
- RLMD 2004
- JUNS 2015
- Country
- RLMD United States
- JUNS United States
- Employees
- RLMD N/A
- JUNS N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- JUNS
- Sector
- RLMD Health Care
- JUNS
- Exchange
- RLMD Nasdaq
- JUNS NYSE
- Market Cap
- RLMD 22.0M
- JUNS 20.5M
- IPO Year
- RLMD N/A
- JUNS 2024
- Fundamental
- Price
- RLMD $0.67
- JUNS $1.07
- Analyst Decision
- RLMD Buy
- JUNS
- Analyst Count
- RLMD 3
- JUNS 0
- Target Price
- RLMD $5.00
- JUNS N/A
- AVG Volume (30 Days)
- RLMD 478.7K
- JUNS 699.7K
- Earning Date
- RLMD 08-06-2025
- JUNS 08-11-2025
- Dividend Yield
- RLMD N/A
- JUNS N/A
- EPS Growth
- RLMD N/A
- JUNS N/A
- EPS
- RLMD N/A
- JUNS N/A
- Revenue
- RLMD N/A
- JUNS N/A
- Revenue This Year
- RLMD N/A
- JUNS N/A
- Revenue Next Year
- RLMD N/A
- JUNS N/A
- P/E Ratio
- RLMD N/A
- JUNS N/A
- Revenue Growth
- RLMD N/A
- JUNS N/A
- 52 Week Low
- RLMD $0.24
- JUNS $0.51
- 52 Week High
- RLMD $4.47
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- RLMD 52.84
- JUNS N/A
- Support Level
- RLMD $0.67
- JUNS N/A
- Resistance Level
- RLMD $0.72
- JUNS N/A
- Average True Range (ATR)
- RLMD 0.08
- JUNS 0.00
- MACD
- RLMD -0.03
- JUNS 0.00
- Stochastic Oscillator
- RLMD 40.29
- JUNS 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.